Journal of Tongji Medical University

, Volume 16, Issue 3, pp 134–138 | Cite as

Investigation on the purification and expression of cell I — Hep I recombinant FN polypeptide inE. Coli

  • Zhang Guimei
  • Feng Zuohua
  • Li Dong
  • Zhang Hui


An anti-metastatic polypeptide, bifunctional-domain (Cell I -Hep I) recombinant polypeptide of human fibronectin, was expressedin E. coli and purified. The expression level was found to be about 20%– 30 % of the total cell proteins. In BL21 (DE3)/T7, anE. coli expressing system, lactose can be used as an inducer to substitute IPTG thereby reducing the cost by several hundredfold and it is suitable for the large-scale preparation of recombinant FN polypeptide. Cell I -Hep 1 fragment is an alkaline polypeptide. In BL21(DE3)/T7 expressing system, better isolation was achieved if DEAE-52, instead of CM-52, was used for ion-exchange chromatography. The purified product was obtained after heparin-agarose affinity chromatography following ion-exchange chromatography.

Key words

fibronectin recombinant polypeptide induced expression purification metastasis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kornblihtt A, Umezawa K, Vibe-Pedersen Ket al. Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. The EMBO J, 1985, 4(7): 1755Google Scholar
  2. 2.
    Kimizuka F, Taguchi Y, Ohaate Yet al. Production and Characterization of functional domains of human fibronection expressed in Escherichia coli. J Biochem, 1991, 110: 284PubMedGoogle Scholar
  3. 3.
    Saiki I, Makabe T, Yoneda Jet al. Inhibitory effect of fibronection and its recombinant polypeptides on the adhesion of metastatic melanoma cells to laminin. Jpn J Cancer Res, 1991, 82: 1112PubMedGoogle Scholar
  4. 4.
    Matsumoto Y, Saiki Y, Makabe Tet al. Inhibitory effect of antimetastatic fusion polypeptide of human fibronectin on tumor cell adhesion to. extracellular matrices. Jpn J Cancer Res, 1991, 82: 1130PubMedGoogle Scholar
  5. 5.
    Yoneda J, Saiki I, Kobayashi Het al. Inhibitory effect of recombinant fibronectin polypeptides on the adhesion of liver-metastatic lymphoma cells to hepaticsinusoidal endothe-lial cells and tumorinvasion. Jpn J Cancer Res, 1994, 85: 723PubMedGoogle Scholar
  6. 6.
    Saiki I, Murata J, Makabe Tet al. Inhibition of lung metastasis by synthetic and recombinant fragments of human fibronectin with functional domains. Jpn J Cancer Res, 1990, 81: 1003PubMedGoogle Scholar
  7. 7.
    Saiki I, Matsumoto Y, Murata Jet al. Recombinant fusion polypeptide with Celland Heparin-binding domains of fibronectin inhibits liver metastasis of L5178Y-ML25 lymphoma cells. Jpn J Cancer Res, 1991, 82: 1120PubMedGoogle Scholar
  8. 8.
    Feng Zuohua, Zhang Guimei, Li Donget al. Construction of expressing plasmids of recombinant FN polypeptides with bifunctional-domain and the characterization of the products expressed inE. coli. J Tongji Med Univ, 1996, 16(2): 70Google Scholar
  9. 9.
    Studier F W, Moffatt B A. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression cloned geges. J Mol Biol, 1986, 189: 113PubMedCrossRefGoogle Scholar

Copyright information

© Tongji Medical University 1996

Authors and Affiliations

  • Zhang Guimei
    • 1
  • Feng Zuohua
    • 1
  • Li Dong
    • 1
  • Zhang Hui
    • 1
  1. 1.Department of Medical Molecular BiologyTongji Medical UniversityWuhan

Personalised recommendations